KLHDC2 activators include a range of chemical compounds that enhance its functional activity through various biochemical mechanisms. Some of these activators function by increasing intracellular levels of cyclic AMP (cAMP), a secondary messenger known to activate protein kinase A (PKA). Once activated, PKA can phosphorylate target proteins, thus potentially enhancing the functional activity of KLHDC2 through phosphorylation events. These cAMP elevating compounds work through different mechanisms; some directly stimulate adenylyl cyclase to produce cAMP, while others inhibit the enzymatic breakdown of cAMP, thereby sustaining its signaling effect. Additionally, certain activators that mimic cAMP can permeate cell membranes and activate PKA internally, leading to the same outcome of potentially increased KLHDC2 activity.
Other pathways influencing KLHDC2 activity involve the modulation of intracellular calcium levels. Compounds that act as calcium ionophores cause an influx of calcium ions, which can activate a variety of calcium-sensitive signaling cascades. These cascades can then indirectly influence the activity of KLHDC2, potentially enhancing its function. Moreover, activators that initiate kinase signaling pathways, such as those activated by growth factors, can lead to a chain reaction of phosphorylation events that may include KLHDC2. Oxidative signaling molecules and nitric oxide donors can further modulate signaling pathways through the activation of redox-sensitive enzymes or cGMP-dependent kinases, respectively.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases intracellular cAMP, potentially boosting KLHDC2 activity via PKA-dependent phosphorylation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific phosphodiesterase inhibitor that prevents cAMP breakdown, potentially increasing PKA activity and thereby enhancing KLHDC2 activity through phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may indirectly increase KLHDC2 activity through PKC-mediated signaling pathways that could phosphorylate and activate KLHDC2. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially activating calcium-sensitive pathways that could lead to the enhancement of KLHDC2 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that could increase intracellular calcium, potentially stimulating calcium-dependent signaling pathways that indirectly enhance KLHDC2 activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that can permeate cell membranes, potentially activating PKA and enhancing KLHDC2 activity through PKA-mediated phosphorylation pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a stable cAMP analog that may activate PKA, potentially leading to the phosphorylation and enhanced activity of KLHDC2. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Is involved in oxidative signaling and can activate redox-sensitive pathways that might lead to the post-translational modification and activation of KLHDC2. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which can lead to the phosphorylation of downstream proteins that may include KLHDC2, thereby enhancing its activity. | ||||||